Inhibin and ovarian cancer
Henry Burger(Hudson Institute of Medical Research), Jock K. Findlay, Karen Verity(Monash Medical Centre), Anna Baillie(Monash Institute of Medical Research), Peter J. Fuller(Hudson Institute of Medical Research), Yan Shen(Monash Medical Centre), Pamela Mamers(Monash Institute of Medical Research), Thomas W. Jobling(Monash Medical Centre), David Robertson(Institute of Cancer Research), D. Healy(Monash Medical Centre), Nigel P. Groome(Oxford Brookes University), Ann E. Drummond(University of Auckland), N Cahir(Monash Medical Centre), B. Susil(Monash Medical Centre)
Cited by 38
Related Papers
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
|The Journal of Clinical Endocrinology & Metabolism|2010|678
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
|Pharmacological Reviews|2006|430
The role of steroids in follicular growth
|Reproductive Biology and Endocrinology|2006|363
Inhibin B as a Serum Marker of Spermatogenesis: Correlation to Differences in Sperm Concentration and Follicle-Stimulating Hormone Levels. A Study of 349 Danish Men<sup>1</sup>
|The Journal of Clinical Endocrinology & Metabolism|1997|300